Small Cap Feast
Small Cap Feast – 08 January 2021
Dish of the Day:
No joiners today
No joiners today
Off the Menu:
No leavers today
No leavers today
What’s Cooking in the IPO Kitchen?
Upon Admission to AIM, Nightcap will acquire The London Cocktail Club Limited (the “London Cocktail Club”), which is an award winning independent operator of ten individually themed cocktail bars in nine London locations and one location in Bristol. Offer TBC Due mid Jan.
HSS Hire Group, HSS.L transfer from Main to Aim. Mkt Cap c. £70m. Recently raised £52.6m. Leading supplier of tool and equipment for hire in the United Kingdom and Ireland and has provided equipment hire services in the United Kingdom for more than 60 years, primarily focusing on the B2B market. Due 14 Jan.
VH Global Sustainable Energy Opportunities plc, a closed-ended investment Company focused on making sustainable energy infrastructure investments, today announces intends to launch an initial public offering of shares on the Official List (Premium) of the Main Market of the London Stock Exchange. Due by Early Feb.
Premier Miton 155.5p £245.6m (PMI.L)
Premier Miton Group plc updated on its unaudited statement of Assets under Management for the first quarter of its current financial year.
- Closing AuM of £12.0 billion at 31 December 2020 (30 September 2020: £10.6 billion)
- Net inflows of £166 million during the Quarter
During the Quarter, the final operational stages of the integration of the former Premier and Miton businesses were completed. This allows the Group to move forward with a single operating platform across the entire fund range.
Rambler Metals and Mining 0.34p £27.66m (RMM.L)
The copper and gold producer, explorer, and developer, advises that effective immediately, Mr Eason Chen has been appointed Chief Financial Officer for the Company and all its subsidiaries on a full-time basis. Mr Chen has served on the board of Rambler for the past eight years as a non-executive director and with his appointment as CFO, he will transition to an executive director role.
The Compensation, Governance and Nomination Committee has embarked on a search for new independent directors to fill the posts recently vacated by Glenn Poulter and Eason Chen. Announcements on these appointments will be made in due course.
Mr Sanjay Swarup has resigned as CFO to pursue other interests and will remain available to the Company for at least the next four months to assist with the transition of the function.
Surgical Innovations 1.8p £16.8m (SUN.L)
The designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery, announces that Distalmotion SA, a Swiss-based medical device company providing robotic surgery systems on a transparent and fair per-procedure cost (Distalmotion), has received European CE Mark for its ‘Dexter’ surgical robot. Manufactured in Switzerland, Dexter combines the affordability of laparoscopy with the benefits of robotic surgery to bring simplicity and versatility in minimally invasive surgical care.
Elemental Healthcare Limited, a wholly owned SI subsidiary, has exclusive UK distribution rights for the Dexter Robot. The European CE mark remains valid in the UK post Brexit.
Baron Oil 0.0925p £4.1m (BOIL.L)
The oil and gas exploration company with opportunities in SE Asia, Latin America and the UK, provided an update on the Chuditch Production Sharing Contract
- Proposal presented to ANPM (Autoridade Nacional do Petróleo e Minerai ) to allow project to progress
Includes request for minimum 12-month extension
- Significant upgrade in estimated resources
Gross Mean GIIP: 4,703 BCF
Gross Mean Prospective Resources: 3,527 BCF
Mean Prospective Resources net to Baron interest: 882 BCF
ITM Power 587p £3.2bnm (ITM.L)
The Fuel Cells and Hydrogen 2 Joint Undertaking (FCH2-JU), a public private partnership of the European Commission, has awarded the consortium behind the OYSTER project, consisting of ITM Power, Ørsted, Siemens Gamesa Renewable Energy, and Element Energy EUR 5 million to investigate the feasibility and potential of combining an offshore wind turbine directly with an electrolyser and transporting renewable hydrogen to shore. The consortium will develop and test a megawatt-scale fully marinised electrolyser in a shoreside pilot trial. The project will be coordinated by Element Energy.
Tremor International 433p £577.1m (TRMR.L)
The specialist in video advertising technologies, provides an update on trading for the year ended 31 December 2020. The Company’s record revenue and profit growth in the second half of 2020 continued through to the year-end, with trading in the month of December at a record high and materially exceeding the Company’s expectations. Therefore, Tremor expects trading for the year ended 31 December 2020 to be ahead of the ranges outlined in its most recent trading statement on 30 November. These were revenues, net revenue and Adjusted EBITDA in the ranges of $390-400 million, $171-175 million and $50-52 million respectively.
Tremor now expects to report revenues of $404-408 million, net revenues of $179-181 million and Adjusted EBITDA of $58-60 million for the year ended 31 December 2020. In addition, the Company had net cash at 31 December 2020 of c. $96 million (30 June 2020: $ 78 million ). This trading performance demonstrates a 72% growth in revenues for Q4 2020 compared to Q4 2019 and 50% growth in the second half of 2020, compared to H2 2019.
Malvern International 0.175p £2.1m (MLVN.L)
The global learning and skills development partner, announces that it has entered into a new short term loan agreement for £350,000 with Boost & Co. Ltd, and that it has secured a further £30,000 via a unsecured loan note with a Director.
The purpose of this new borrowing is to provide bridging finance to ensure the Company has sufficient working capital pending the payment of a significant trade debtor amounting to in excess of £900,000 which is expected to be paid in quarter one 2021.
88 Energy 0.565p £60.2m (88E.L)
88 Energy, via its wholly owned subsidiary Regenerate Alaska Inc, has been named high bidder on Tract 29 in the 2021 Coastal Plain Lease Sale. Tract 29 is comprised of 23,446 acres and is adjacent to 88 Energy’s existing Yukon Leases as well as the Point Thomson gas condensate field, which is currently in production. The acquisition of these leases represents a logical step in the Company’s aggregation strategy for oil resources in this part of the North Slope, where existing infrastructure provides a potential pathway to commercialisation.
Immedia 32p £8.2m (IME.L)
The supplier of multi-media content and digital solutions for leading brands and global businesses, announces that it has conditionally raised gross proceeds for £3.0 million at 25p with 1 for 1 warrants. In the circular to Shareholders published on 20 August 2020 the Company set out its rationale for raising additional working capital to secure the business in the context of the CVID-19 pandemic, which, as announced n 6 April and 18 June 2020, materially affected both the Group’s retail and project customers.
The uncertainty of trading conditions caused by the pandemic remains. However, since the pandemic began there has been a significant reduction in the operating costs of the business and IME continue t maintain a prudent trading outlook for 2021, and Q1 in particular.
Anpario 505p £117m (ANP.L)
Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity announced the appointment of Matthew Robinson as a Non-Executive Director of the Company with effect from 11 January 2021.
Matthew Robinson has spent much of his career working with and advising growth companies and is currently Non-Executive Chairman of AIM listed Goldplat plc. Matthew started his career as a Chartered Accountant and was previously a Corporate Finance Director at finnCap and Panmure Gordon.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.